PKU HealthCare Corp Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PKU HealthCare Corp Ltd with three other
companies in this sector in CHINA :
Asymchem Laboratories Tian Jin Co Ltd
sales of 2.46 billion Chinese Renmimbi [US$361.22 million]
of which 100%
was Pharmaceutical industry),
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd
(2.47 billion Chinese Renmimbi [US$362.65 million]
of which 100%
was Pharmaceutical manufacture), and
Hainan Haiyao Company Limited
(2.45 billion Chinese Renmimbi [US$359.07 million]
of which 70%
PKU HealthCare Corp Ltd reported sales of 2.51 billion Chinese Renmimbi (US$368.43 million)
December of 2019.
increase of 8.3%
versus 2018, when the company's sales were 2.32 billion Chinese Renmimbi.
This was the fourth straight year of sales growth at PKU HealthCare Corp Ltd.
Sales of Medicine Production saw an increase
that was more than double the company's growth rate: sales were up
25.6% in 2019, from
712.09 million Chinese Renmimbi to 894.11 million Chinese Renmimbi.
Not all segments of PKU HealthCare Corp Ltd experienced an increase in sales in 2019:
sales of Other Operation fell 30.6% to 13.35 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).
PKU HealthCare Corp Ltd also experienced decreases in sales in
Others (down 13.5% to 2.90 million Chinese Renmimbi)